Dabur India on Tuesday moved Delhi High Court against Patanjali Ayurved over the latter’s Chyawanprash ads. It has said that Patanjali’s advertisement in print and on TV has been released with ...

NEW DELHI: FMCG segment leader Dabur approached the Delhi High Court on Tuesday, alleging that Patanjali Ayurved has been running advertisements that disparage its Chyawanprash products.

Dabur contends that the ad unfairly suggests other ... Dabur has argued that Patanjali’s advertisement, which has been broadcast over 900 times on TV and featured in newspapers recently, not ...

NEW DELHI: The Delhi High Court has sought Patanjali Ayurved's stand on a lawsuit ... claim in the impugned TVC and in the impugned print ad that only the Ayurvedic book used by the defendants ...

New Delhi: The Delhi High Court has sought Patanjali Ayurved's stand on a lawsuit ... claim in the impugned TVC and in the impugned print ad that only the Ayurvedic book used by the defendants ...

Dabur has moved the Delhi high court against Patanjali Ayurved for alleged disparaging ads against the FMCG major's Chyawanprash products. Dabur has sought that Patanjali should be immediately ...

New Delhi: The Delhi High Court has sought Patanjali Ayurved's stand on a lawsuit ... claim in the impugned TVC and in the impugned print ad that only the Ayurvedic book used by the defendants ...

The Patanjali has been running on various TV channels and has also been published in the Delhi edition of a newspaper. Senior Advocate Akhil Sibal also said that Patanjali Ayurved has been a ...

That left room for Johnson & Johnson’s Tremfya to jump up to the second spot, while Novo Nordisk’s megapopular obesity med Wegovy—a recent addition to iSpot.TV’s pharma ad spending ...

Hays Travel has screened the first of three new TV adverts over the festive holiday ... and choice we give our customers.” “Our three ads demonstrate the breadth of holiday product we can ...

Skyrizi had an estimated national TV ad spend of $367.7 million — the highest ad spend of any brand in the top 10. During 2024, Skyrizi was named the top Rx and OTC for TV advertising in Q2 and Q3 as ...